B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure

B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure

Abstract Fluid overload is a common complication in patients with cirrhosis. B-type natriuretic peptide (BNP) is a marker of increased blood volume, commonly used in heart failure, that has been shown to be elevated in patients with liver disease. This study examined if BNP levels can be used to det...

Full description

Bibliographic Details
Main Authors: Tiago Araujo, Ishaan Vohra, Pedro Palacios, Vatsala Katiyar, Estefania Flores, Tejinder Randhawa, Yuchen Wang, Yazan Abu-Omar, Vijaya Mukthinuthalapati, Hemant Mutneja, Sanjay A. Patel, Bashar Attar
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-78946-3

Internet

https://doi.org/10.1038/s41598-020-78946-3

Similar Items